112 related articles for article (PubMed ID: 23482804)
1. DNA ploidy: a prognostic factor of response to chemotherapy and survival in metastatic gastric adenocarcinoma.
Syrios J; Kechagias G; Agrogiannis G; Xynos ID; Kavantzas N; Lazaris AC; Amptoulach S; Mourati A; Sougioultzis S; Patsouris ES; Tsavaris N
Anticancer Res; 2013 Mar; 33(3):1209-14. PubMed ID: 23482804
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
[TBL] [Abstract][Full Text] [Related]
3. Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer.
Setälä LP; Nordling S; Kosma VM; Lipponen PK; Eskelinen MJ; Hollmén SM; Syrjänen KJ; Alhava EM
Anal Quant Cytol Histol; 1997 Dec; 19(6):524-32. PubMed ID: 9893908
[TBL] [Abstract][Full Text] [Related]
4. Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer.
Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S
Anticancer Res; 1997; 17(4B):2923-6. PubMed ID: 9329565
[TBL] [Abstract][Full Text] [Related]
5. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA measurement of gastric cancers. Clinico-pathological implication of DNA ploidy.
Sasaki K; Takahashi M; Hashimoto T; Kawachnino K
Pathol Res Pract; 1989 Jun; 184(6):561-6. PubMed ID: 2780430
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy as a prognostic factor for patients with an adenocarcinoma in Barrett's esophagus.
Menke-Pluymers MB; Hop WC; Mulder AH; Tilanus HW
Hepatogastroenterology; 1995; 42(6):786-8. PubMed ID: 8847023
[TBL] [Abstract][Full Text] [Related]
11. [Heterogeneity in gastric carcinoma with special reference to DNA content and mitotic activity: histopathologic differentiation].
Ooiwa H; Saito A; Tomisaki S; Oshiro T; Okuyama T; Oono S; Baba H; Maehara Y; Sugimachi K
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():17-20. PubMed ID: 8203924
[TBL] [Abstract][Full Text] [Related]
12. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
13. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.
Esteban F; de Vega DS; Garcia R; Rodriguez R; Manzanares J; Almeida A; Tamames S
Hepatogastroenterology; 1999; 46(27):2039-43. PubMed ID: 10430394
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy is a major prognostic factor in advanced gastric carcinoma--univariate and multivariate analysis.
Haraguchi M; Watanabe A; Moriguchi S; Korenaga D; Maehara Y; Okamura T; Sugimachi K
Surgery; 1991 Nov; 110(5):814-9. PubMed ID: 1948649
[TBL] [Abstract][Full Text] [Related]
16. [DNA ploidy pattern as an indicator of degree of malignancy and prognosis in gastric cancer].
Kitamura M; Arai K; Miyashita K; Takahashi K; Kato H; Takamoto S; Maeda Y
Nihon Rinsho; 1992 Oct; 50(10):2401-7. PubMed ID: 1447810
[TBL] [Abstract][Full Text] [Related]
17. Is DNA ploidy and proliferative activity of prognostic value in advanced gastric carcinoma?
Filipe MI; Rosa J; Sandey A; Imrie PR; Ormerod MG; Morris RW
Hum Pathol; 1991 Apr; 22(4):373-8. PubMed ID: 2050371
[TBL] [Abstract][Full Text] [Related]
18. Nuclear DNA content, tumor cell aggregation, and metastatic events in patients with poorly differentiated adenocarcinoma of the stomach.
Watanabe A; Korenaga D; Maehara Y; Sugimachi K
Cancer; 1991 Aug; 68(4):815-20. PubMed ID: 1855182
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative estimation of malignancy of gastric cancer by DNA ploidy and proliferative activities].
Yonemura Y; Miyazaki I
Rinsho Byori; 1990 Sep; 38(9):1053-8. PubMed ID: 2232266
[TBL] [Abstract][Full Text] [Related]
20. [Results of flow image analytic DNA determination in histologic preparations of malignant tumors].
Harosek G; Theissig F; Dimmer V; Kunze KD; Meyer W
Acta Histochem Suppl; 1990; 39():139-45. PubMed ID: 1964230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
